Evidence map›Paper›PMID 24296352›Full record

ReviewCold Spring Harbor perspectives in medicine2013

T-cell costimulatory blockade in organ transplantation.

Jonathan S Maltzman, Laurence A Turka

Abstract readReview
In one paragraph

Review in Cold Spring Harbor perspectives in medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Advancing mouse models for transplantation research.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2024
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Tolerance--is it worth it?Cold Spring Harbor perspectives in medicine · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jonathan S MaltzmanDepartment of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania 19104.
Laurence A Turka

Funding

Signals Affecting Homestasis and Tolerance in Memory T CellsR01AI085160 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI MALTZMAN, JONATHAN S · 2010 to 2014
$1.9M
NIAID NIH HHS R01 AI085160
6 · The paper itself

Abstract

Before it became possible to derive T-cell lines and clones, initial experimentation on the activation requirements of T lymphocytes was performed on transformed cell lines, such as Jurkat. These studies, although technically correct, proved misleading as most transformed T cells can be activated by stimulation of the clonotypic T-cell receptor (TCR) alone. In contrast, once it became possible to study nontransformed T cells, it quickly became clear that TCR stimulation by itself is insufficient for optimal activation of naïve T cells, but in fact, induces a state of anergy. It then became clear that functional activation of T cells requires not only recognition of major histocompatibility complex (MHC) and peptide by the TCR, but also requires ligation of costimulatory receptors expressed on the cell surface.

Indexed as

AnimalsAntibodiesAntigens, CDCD28 AntigensCD40 AntigensCD40 LigandCD58 AntigensCTLA-4 AntigenHumansInducible T-Cell Co-Stimulator ProteinLymphocyte ActivationOX40 LigandPrimatesProgrammed Cell Death 1 ReceptorT-LymphocytesTransplantation ImmunologyAntibodiesAntigens, CDCD28 AntigensCD40 AntigensCD40 LigandCD58 AntigensCTLA-4 AntigenInducible T-Cell Co-Stimulator ProteinOX40 LigandPDCD1 protein, humanProgrammed Cell Death 1 ReceptorTumor Necrosis Factor Receptor Superfamily, Member 9

Identifiers

PMID24296352
PMCPMC3839597

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.